Exercise News and Research

Latest Exercise News and Research

FDA grants SynCardia Systems conditional approval to conduct IDE study of Freedom driver system

SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to conduct an Investigational Device Exemption (IDE) clinical study of the Freedom™ driver system, the first-ever U.S. portable driver designed to power SynCardia's Total Artificial Heart.

29 Mar 2010

As CMS nominee, Berwick would face changes and challenges

President Barack Obama will soon nominate Dr. Donald M. Berwick to "run Medicare and Medicaid, the programs that serve nearly one-third of all Americans, administration officials said Saturday," The New York Times reports.

29 Mar 2010

China Medicine's 2009 revenues up 20.7%

China Medicine Corporation, primarily a manufacturer, leading distributor and developer of Western pharmaceuticals, traditional Chinese medicines, and other nutraceuticals, today announced its fourth quarter and full year 2009 results.

29 Mar 2010

Surgery helps reduce weight from 118 kg to 62.8 kg

Weight control is one of the important topics for modern people. In addition to proper diet, regular exercise and appropriate use of medicine, obese suffers may consider weight loss surgeries for faster effects. The first successful case in NCKU Hospital reduced her weight from 118 kg to 62.8 kg one year after the surgery.

29 Mar 2010

Inovio Biomedical's total revenue increased to $2.6M for quarter ended December 31, 2009

Inovio Biomedical Corporation today reported financial results for the quarter and year ended December 31, 2009.

29 Mar 2010

American obesity problem: Ongoing support to make lifestyle and behavior changes needed

An administration task force chaired by the U.S. Departments of Agriculture, Education and Health and Human Services is asking the public for recommendations to solve the American obesity problem, and a new poll by the American Psychological Association may have some answers.

29 Mar 2010

IOF invites for Asia-Pacific Osteoporosis Meeting in Singapore

The International Osteoporosis Foundation (IOF) invites you to attend the first of a new series of meetings - the IOF Regionals: Asia-Pacific Osteoporosis Meeting, to be held in Singapore from December 10-13, 2010.

29 Mar 2010

Managing Technetium-99m shortage: MedSolutions provides advisory

MedSolutions, a leading provider of medical management services, has provided an advisory for payors and providers on options regarding the shortage of Technetium-99m (Tc-99m), a radioactive tracer isotope that is widely-used in nuclear medicine studies.

27 Mar 2010

Ford Motor donates $255,000 to fund completion of Oakwood Healthcare System's research study

Ford Motor Company announced today it is donating an additional $255,000 to fund the completion of a pioneering multi-year Oakwood Healthcare System research study into the prevention of heart disease – a leading cause of death among American women.

27 Mar 2010

Helix BioMedix reports revenue of approximately $391,000 in 2009

Helix BioMedix, Inc., a developer of bioactive peptides, announced financial results for the year ended December 31, 2009.

26 Mar 2010

Invida to continue commercialization of Actelion's Tracleer for PAH in crucial Asian markets

Invida Group, the leading provider of healthcare brands and services to the Asia Pacific region, today announced that its contract with Swiss biotechnology company, Actelion, has been extended through 2015 to continue commercialization of Tracleer® for the treatment of pulmonary arterial hypertension (PAH) in crucial markets throughout Asia. Actelion signed with Invida initially in 2005, and has extended the contract to market the company’s lead product, Tracleer, in Thailand, Malaysia, Philippines, Vietnam, and Hong Kong

26 Mar 2010

Muscular dystrophy: $1M grant for study of erectile dysfunction drugs in improving muscle blood flow

A Cedars-Sinai Heart Institute cardiologist has been awarded a three-year, nearly $1 million grant from the Muscular Dystrophy Association (MDA) to study whether drugs used to treat erectile dysfunction could also be used to improve muscle blood flow and reduce fatigue in muscular dystrophy patients.

26 Mar 2010

RXi Pharmaceuticals obtains commitments to purchase 2.7M shares of common stock at $6.00 per share

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference, announced today that it has obtained commitments from several investors to purchase 2.7 million shares of its common stock at $6.00 per share and warrants to purchase 540,000 shares of its common stock for gross proceeds of $16.2 million.

26 Mar 2010

Santarus enrolls 510 patients in Phase III clinical program for budesonide MMX

Santarus, Inc., a specialty biopharmaceutical company, today announced the completion of enrollment of 510 patients in a U.S. Phase III clinical study to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis. This is the second Phase III clinical study being conducted in collaboration with Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA, as part of the budesonide MMX Phase III clinical program for U.S. registration.

26 Mar 2010

BioScrip acquires Critical Homecare Solutions Holdings

BioScrip, Inc. today announced that it has completed its acquisition of Critical Homecare Solutions Holdings, Inc. (“CHS”), a leading provider of home infusion and home nursing products and services to patients suffering from chronic and acute medical conditions.

26 Mar 2010

ASCO, ESMO and OECI endorse WIN Symposium's initiatives on improving outcomes of cancer

The WIN Consortium, supported by its media partner Nature Publishing Group, has opened registration for the second annual WIN Symposium, to be held in the Palais des Congrès, Paris, on the 7th to 9th of July 2010. The WIN Symposium is an open and interactive forum designed to promote rapid translation of ground-breaking personalized cancer medicine discoveries to clinical practice.

25 Mar 2010

Exercise News and Research

Latest Exercise News and Research

FDA grants SynCardia Systems conditional approval to conduct IDE study of Freedom driver system

As CMS nominee, Berwick would face changes and challenges

China Medicine's 2009 revenues up 20.7%

Surgery helps reduce weight from 118 kg to 62.8 kg

Inovio Biomedical's total revenue increased to $2.6M for quarter ended December 31, 2009

American obesity problem: Ongoing support to make lifestyle and behavior changes needed

IOF invites for Asia-Pacific Osteoporosis Meeting in Singapore

Managing Technetium-99m shortage: MedSolutions provides advisory

Ford Motor donates $255,000 to fund completion of Oakwood Healthcare System's research study

Helix BioMedix reports revenue of approximately $391,000 in 2009

Invida to continue commercialization of Actelion's Tracleer for PAH in crucial Asian markets

Muscular dystrophy: $1M grant for study of erectile dysfunction drugs in improving muscle blood flow

RXi Pharmaceuticals obtains commitments to purchase 2.7M shares of common stock at $6.00 per share

Santarus enrolls 510 patients in Phase III clinical program for budesonide MMX

BioScrip acquires Critical Homecare Solutions Holdings

ASCO, ESMO and OECI endorse WIN Symposium's initiatives on improving outcomes of cancer

Book on academic achievements

Chronic job stress linked to obesity

Cardiologist receives grant to study impact of erectile dysfunction drugs on muscular dystrophy patients

SCOLR Pharma's total revenue dips 2% in 2009, but significant improvements in operating expenses

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exercise News and Research

Latest Exercise News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in